Concepedia

Author

Bryan Goldman

SWOG Cancer Research Network

Also Known As

B Goldman, B. Goldman, B. H. Goldman, B.H. Goldman, Bart Goldman, Bryan Goldman, Bryan H Goldman, Bryan H. Goldman, Goldman, Bryan

80

Publications

4.6K

Citations

34

H-Index

74

Concepts

All Affiliations

SWOG Cancer Research NetworkCancer Research And BiostatisticsUniversity of WashingtonOregon Health & Science UniversityUniversity of Michigan
BG

About

Bryan Goldman is an author at SWOG Cancer Research Network specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

632

2

Health Sciences

5

5

277

3

Engineering

2

2

76

4

Public Health

1

1

34

5

Behavioral Sciences

1

1

42

Bryan Goldman

×

44

Publications

4.3K

Citations

34

H-Index

YearCitations

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Stephen R. Smalley, Jacqueline Benedetti, Daniel G. Haller,

Journal of Clinical Oncology

2012

847

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless,

Journal of Clinical Oncology

2010

623

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

Tanya B. Dorff, Bryan Goldman, Jacek Pinski,

Clinical Cancer Research

2010

209

Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

Maha Hussain, Bryan Goldman, Cathy Tangen,

Journal of Clinical Oncology

2009

208

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Guru Sonpavde, Bryan Goldman, V. O. Speights,

Cancer

2009

195

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

Eila C. Skinner, Bryan Goldman, Wael Sakr,

The Journal of Urology

2013

159

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser,

Annals of Oncology

2011

159

Sorafenib With Interferon Alfa-2b As First-Line Treatment of Advanced Renal Carcinoma: A Phase II Study of the Southwest Oncology Group

Christopher W. Ryan, Bryan Goldman, Primo N. Lara,

Journal of Clinical Oncology

2007

152

Prospective noise induced changes to hearing among construction industry apprentices

Noah Seixas, Bryan Goldman, Lianne Sheppard,

Occupational and Environmental Medicine

2005

115

Use of high-intensity focused ultrasound to control bleeding

Shahram Vaezy, Roy W. Martin, Peter Kaczkowski,

Journal of Vascular Surgery

1999

98

Page 1